PT Chandra Asri Pacific Tbk (PTCAY) Fair Value & Analysis
Basic Materials · US · Market cap $7.1B
Fair value as of: Jul 18, 2026
From 12 valuation models · updated 23 days ago
Fair value updated Jul 18, 2026, revised from $14.16 to $4.96 (−65.0%) since Jun 24, 2026.
A solid business, but screening 38% overvalued on our models.
What matters now
- The model range is unusually wide ($3.40 to $14.78). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year. As of Jul 18, 2026.
How to read this chart
60‑month range $0.9602 – $61.05 · fair‑value band $3.40 – $14.78 · the $8.00 price screens above the $4.96 fair value. As of Jul 18, 2026.
Analysis
PT Chandra Asri Pacific Tbk (PTCAY) currently trades at $8.00, while our model-based Fair Value estimate is $4.96, implying the stock looks roughly 38.1% overvalued today. The Quality Score stands at 50/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, PT Chandra Asri Pacific Tbk generated revenue of $8.8B at a net margin of 14.3%. Revenue grew 286.4% year over year. It earns a return on equity of 42.4%. Net debt stands at $2.7B. Fundamentals as of Jul 18, 2026
Our scenario range runs from $3.40 (bear case) to $14.78 (bull case); at $8.00, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 75% below its 52-week high. For context, the median of 10 Basic Materials peers we cover trades at -67% fair-value upside, at -38%, PTCAY screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: Growth Earnings ($32.49) versus Dividend Discount ($0.8700). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 50
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Chandra Asri Pacific Tbk provides chemical and infrastructure solutions in Indonesia and Singapore. It operates through Energy, Chemical, and Infrastructure segments. The company offers olefins, such as ethylene, propylene, pyrolysis gasoline, crude C4, and pyrolysis fuel oil.
Full company description
PT Chandra Asri Pacific Tbk provides chemical and infrastructure solutions in Indonesia and Singapore. It operates through Energy, Chemical, and Infrastructure segments. The company offers olefins, such as ethylene, propylene, pyrolysis gasoline, crude C4, and pyrolysis fuel oil. It also provides polyolefins comprising polyethylene products, including linear low density and high-density polyethylene under the Asrene brand name; and polypropylene products, such as homopolymer, random and impact copolymer, and terpolymer under the Trilene brand name for use in food packaging, housewares, electronics, and automotive products. The company offers styrene monomer, an organic monomer aromatics compound for use in the production of polystyrene, expanded polystyrene, styrene acrylonitrile, acrylonitrile butadiene styrene, styrene butadiene rubber, styrene butadiene latex, and unsaturated polyester resin; butadiene, a conjugated diene to produce styrene-butadiene rubber, adhesives, sealants, coatings, and other rubber products; and raffinate-1 and chlor alkali products. It also engages in the sale of electricity and other electrical services, as well as fuels; wholesale business; leasing of tanks and jetty; and management consulting, warehousing, storage, water treatment, and seaport services. The company offers ethylene dichloride, a chemical input to produce polyvinyl chloride; butene-1, an organic chemical used as a co-monomer of polyethylene polymerization; methyl tert-butyl ether (MTBE), a volatile organic compound; and raffinate-2, a by-product of MTBE used as feedstock. It also exports its products. The company was formerly known as PT Chandra Asri Petrochemical Tbk and changed its name to PT Chandra Asri Pacific Tbk in January 2024. The company was founded in 1984 and is headquartered in Jakarta, Indonesia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Chandra Asri Pacific Tbk reported revenue of $7.0B in FY2025 versus $2.6B in FY2021, a compound +28.4%/yr. Reported net income was $1.1B in FY2025, compounding +63.6%/yr from FY2021.
PTCAY screens 38% overvalued. Compare with Linde plc →
Peer Group
Specialty Chemicals · 676 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $489.98 | $222.03 | -55% |
| Nan Ya Plastics Corporation 1303 | 181.50 TWD | 255.83 TWD | +41% |
| Wanhua Chemical Group 600309 | ¥70.04 | ¥68.03 | -3% |
| Novozymes A/S NSISB | kr 428.20 | kr 179.66 | -58% |
| Asian Paints Limited ASIANPAINT | ₹2,689 | ₹668.81 | -75% |
| Solar Industries India Limited SOLARINDS | ₹18,236 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,560 | ₹351.84 | -77% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
| Berger Paints India Limited BERGEPAINT | ₹493.70 | ₹164.29 | -67% |
| Gujarat Fluorochemicals Limited FLUOROCHEM | ₹4,132 | ₹836.47 | -80% |
Compare PT Chandra Asri Pacific Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is PT Chandra Asri Pacific Tbk (PTCAY) overvalued or undervalued?
What is the fair value of PTCAY?
What is the quality score of PTCAY?
What is the revenue of PT Chandra Asri Pacific Tbk (PTCAY)?
What is the net profit margin of PTCAY?
Does PT Chandra Asri Pacific Tbk pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Chandra Asri Pacific Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.